Abstract
Developing biocompatible polymeric platforms for drug delivery with enhanced localized activity represents a key facet of advanced interventional therapy. In this work, the drug-eluting potential of an amine-functionalized poly- p-xylene commonly known as Parylene A (4-amino(2,2)paracyclophane) was conducted with the microfilm device consisting of a primary base layer, drug film, and a secondary eluting layer presenting exposed amine groups which enhance the range of modifications that can be incorporated into the film. The murine macrophage cell line RAW 264.7 served as a cellular response to dexamethasone, a synthetic anti-inflammatory glucocorticoid and doxorubicin, an anticancer therapeutic. Decreased expression of NFkappa-B-mediated cytokines Interleukin-6 (IL-6) and Tumor Necrosis Factor-alpha (TNFalpha), resultant DNA fragmentation, and spectroscopic analysis revealed the efficient and localized drug-eluting properties of the Parylene A polymeric bilayer.
Publication types
-
Research Support, N.I.H., Extramural
-
Research Support, U.S. Gov't, Non-P.H.S.
MeSH terms
-
Amines / chemistry
-
Animals
-
Anti-Inflammatory Agents / administration & dosage
-
Anti-Inflammatory Agents / pharmacology
-
Antineoplastic Agents / administration & dosage
-
Antineoplastic Agents / pharmacology
-
Biocompatible Materials / administration & dosage*
-
Biocompatible Materials / chemistry
-
Biocompatible Materials / pharmacology
-
Cell Line
-
Cytokines / metabolism
-
DNA Fragmentation
-
Dexamethasone / administration & dosage
-
Dexamethasone / pharmacology
-
Doxorubicin / administration & dosage
-
Doxorubicin / pharmacology
-
Drug Delivery Systems*
-
Glucocorticoids / administration & dosage
-
Glucocorticoids / pharmacology
-
Interleukin-6 / metabolism
-
Macrophages / metabolism
-
Mice
-
NF-kappa B / metabolism
-
Polymers / chemistry*
-
Time Factors
-
Tumor Necrosis Factor-alpha / metabolism
-
Xylenes / chemistry*
Substances
-
Amines
-
Anti-Inflammatory Agents
-
Antineoplastic Agents
-
Biocompatible Materials
-
Cytokines
-
Glucocorticoids
-
Interleukin-6
-
NF-kappa B
-
Polymers
-
Tumor Necrosis Factor-alpha
-
Xylenes
-
4-xylene
-
Dexamethasone
-
Doxorubicin